Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Drug Investigation|December 23, 2015
Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact AnalysisIvar S Jensen, Thomas P Lodise, Weihong Fan, et al.
Circulation. Cardiovascular Interventions|January 10, 2016
Bivalirudin Is Associated With Improved In-Hospital Outcomes Compared With Heparin in Percutaneous Vascular Interventions: Observational, Propensity-Matched Analysis From the Premier Hospital DatabaseCarey Kimmelstiel, Duane Pinto, Herbert D Aronow, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 3, 2015
Cost implications of intraprocedural thrombotic events during PCIStephanie Plent, Weihong Fan, Ajay Kirtane, et al.
Journal of Thrombosis and Thrombolysis|August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover studyFrancesco Franchi, David J Schneider, Jayne Prats, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 27, 2015
Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational databaseDuane S Pinto, Payal Kohli, Weihong Fan, et al.
JHLT Open|September 11, 2025
Intraoperative antithrombotic drug removal during heart transplantation: A case series from the International Safe and Timely Antithrombotic Removal (STAR) registryJan Schmitto, Filip De Somer, Matthias Thielmann, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2018
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS StudyHector Tamez, Philip Généreux, Robert W Yeh, et al.
Renal Failure|December 16, 2025
Hemoadsorption therapy in severe rhabdomyolysis: a report from the international, prospective COSMOS (CytOSorb<sup>®</sup> TreatMent of Critically ill PatientS) registryRicard Ferrer, Bartosz Tyczynski, Julian Kreutz, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 25, 2026
Randomized, Sham-Controlled Trial of Intraoperative Ticagrelor Removal to Reduce Perioperative BleedingMichael J Mack, Richard Whitlock, Michael W A Chu, et al.
Journal of Intensive Medicine|November 3, 2025
The international, prospective CytOSorb<sup>Ⓡ</sup> treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patientsRicard Ferrer, Matthias Thielmann, Andreas Kribben, et al.
Pageof 6